Coexistence of psoriasis and pemphigus after enalapril intake.
Panagiotis G
PG
Stavropoulos
Panagiotis G
PG
Kostakis
Anastasia-Metaxia K
AM
Papakonstantinou
Antonios
A
Panagiotopoulos
Athanassios D
AD
Petridis
D000287:Administration, Topical; D000368:Aged; D001623:Betamethasone / Q000627:therapeutic use; D004656:Enalapril / Q000009:adverse effects* / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D010392:Pemphigus / Q000139:chemically induced* / Q000150:complications* / Q000188:drug therapy; D011565:Psoriasis / Q000150:complications* / Q000175:diagnosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D004656:Enalapril; D001623:Betamethasone